Skip to main content

Home/ MaRS/ Group items matching "labs" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
Assunta Krehl

reportonbusiness.com: THE COMPANY: INFONAUT INC.: Charting the right course through an outbreak - 0 views

www.theglobeandmail.com/...Business

Infonaut software

shared by Assunta Krehl on 04 May 09 - Cached
  • Toronto, where a small firm is using 21st-century software to create maps with similar goals - the containment of disease - by showing infection patterns that can be understood at a glance.
  • Toronto, where a small firm is using 21st-century software to create maps with similar goals - the containment of disease - by showing infection patterns that can be understood at a glance.
  • There's nothing wrong with Infonaut using the H1N1 flu outbreak to gain exposure, as long as the company is careful in the tone it takes, said John Lute, president of Toronto communications firm Lute and Co.
  • ...15 more annotations...
  • Infonaut Inc. chief executive officer Niall Wallace and his partner, chief operating officer Matt McPherson, both former IT consultants for the Ontario government, created the company after helping to craft some of the recommendations that resulted from the SARS outbreak of 2003. They understood the value of visually represented, real-time infection data, and left government to set up Infonaut to develop that technology.
  • Infonaut has created three software products that turn infection information into maps. All are being tested in pilot projects and will soon be marketed commercially.
  • One, called Infection Watch Live, is now taking data gathered at 14 hospital emergency rooms in eastern Ontario and using it to create publicly accessible maps that show exactly where in the region cases of influenza and gastrointestinal diseases are active.
  • This complex mapping can help monitor and stop the spread of C. difficile and other superbugs.
  • The third product, called Regional Watch Live, generates maps and reports for regional health professionals by merging lab test results with a range of other information.
  • INFONAUT INC
  • Make sure to present straightforward information about how the company's products might help mitigate an outbreak in the future, but do not exaggerate promises. Be upfront about the state of pilot tests, the timelines to get the software to market, and how much funding will be needed to go to full commercialization. Use respected third-party partners to endorse the products, a move that will give the company more credibility. If there are privacy concerns, spell them out and detail how they are being addressed.
  • Infonaut should ensure that its message is understated and that the company is not an "ambulance chaser," Mr. Lute said
  • But the company does need to give straightforward information about how its products might help mitigate an outbreak in the future, and not exaggerate its promises, she said. In particular, it needs to be upfront about the state of its pilot tests and include details of when full versions of its products will be available. It also must explain how much funding they will need to get there, Ms. Wilcox said.
  • With Infonaut, there seems to be no question that there is a public gain, he said. "If it is just an opportunistic attempt to cash in on the misfortune of others, that tends to play badly. Where a company has something that can be tied to the public interest, such as in this case ... it is very low-risk."
  • He suggests that Infonaut make good use of its pilot test partners, such as the counties in eastern Ontario that are testing the Infection Watch Live system.
  • the company should forestall any concerns over privacy issues by spelling out how it ensures data on individuals are kept confidential.
  • There's nothing wrong with using the current concerns over H1N1 flu to gain exposure, as long as Infonaut is careful about taking a calm and respectful tone to its marketing and publicity.
  • On the other hand, it will clearly create an opportunity if Infonaut can increase its profile, "which helps it to get its story out, which helps it to get investors, which helps it to grow.
  • The problem Build a market for a unique infection mapping system without appearing to exploit the flu outbreak The plan: Use a subtle approach and be upfront with the state of development of the software products The payoff: Higher awareness among potential customers and an expanded market
  • Assunta Krehl on 04 May 09
     
    Using 21st-century Infonaut is using software to create maps - the containment of disease - by showing infection patterns that can be understood at a glance.
Assunta Krehl

Researcher's Kyoto Prize celebrated - University of Toronto - 0 views

www.news.utoronto.ca/...rs-kyoto-prize-celebrated.html

awards & competition Kyoto University of Toronto

shared by Assunta Krehl on 14 Aug 09 - Cached
  • Toronto hosted a celebration Feb. 18 honouring Canada's first two Kyoto Prize laureates: University Professor Anthony Pawson of molecular genetics and McGill University's Charles Taylor, a philosopher.
  • Pawson, a world-renowned cell biologist and Mount Sinai Hospital distinguished investigator, received the prize in basic science for his studies of cellular communication. He will receive a 20-karat gold medal and a cash gift of 50 million yen (approximately $460,000 Cdn).
  • He and Taylor, who won the prize in the arts and philosophy category, delivered a joint lecture during the celebratory event at MaRs (Medical and Related Sciences Discovery District).
  • ...1 more annotation...
  • Pawson was recognized for his research into the way cells communicate with each other, which has made possible the development of drugs that halt the multiplication of certain types of cancer cells, among other breakthroughs. His lab has helped lay the groundwork for this new generation of drugs.
  • Assunta Krehl on 14 Aug 09
     
    University Professor Anthony Pawson of molecular genetics and McGill University's Charles Taylor, a philosopher where honoured as Canada's first two Kyoto Prize winners. Mention of Pawson and Taylor delivering a joint lecture at MaRS during the event.
  • Assunta Krehl on 14 Aug 09
     
    University Professor Anthony Pawson of molecular genetics and McGill University's Charles Taylor, a philosopher where honoured as Canada's first two Kyoto Prize winners. Mention of Pawson and Taylor delivering a joint lecture at MaRS during the event. Feb 20, 2009
Cathy Bogaart

2010: Marketing is not Marketing | - 1 views

blog.tippingpointlabs.com/...010-marketing-is-not-marketing

marketing

shared by Cathy Bogaart on 03 Mar 10 - Cached
  • Don’t just email them one-way marketing spam featuring the next product you want them to purchase.
  • You need to build an entire support ecosystem that allows you to channel conversations to the right place.
  • If you believe in your brand, your workplace, and your employees then you have nothing to hide. If you do have something to hide, fix it, because no amount of marketing will.
  • ...3 more annotations...
  • They are a visionary; they’re always the smartest person in the room, and they drop gorgeous nuggets of wisdom without even realizing it. Elevate them! They should be blogging and Tweeting daily.
  • But don’t make them just shill for the brand.
  • Give the lowest member of the customer support team a vehicle to share his ideas with the product development team.
  • Cathy Bogaart on 03 Mar 10
     
    Brett Virmalo of Foward Thinking writes a great must-read about what the "new marketing" really is: your customers and your employees and really great products. Stop marketing. Start being genuinely good. It's the "new" secret sauce.
Assunta Krehl

* Printer friendly version * Email story to a friend * Send your comments to the editor * Personal News Alerts Related Items Topics * Collaborations * Life Sciences MaRS Innovation and CDRD announce strategic collaboration - Lab Can - 1 views

www.labcanada.com/...ISArticle.asp

Healthcare Therapeutics MaRS Innovation innovative organizations Centre for Drug Research and Development Rafi Hofstein Collaboration

shared by Assunta Krehl on 15 Dec 09 - Cached
  • Assunta Krehl on 15 Dec 09
     
    MaRS Innovation (MI) and the Centre for Drug Research and Development (CDRD) are pleased to announce that they have entered into an agreement to collaborate on projects of mutual interest with a goal to advance and commercialize early-stage health-related discoveries. Dec 15, 2009
Assunta Krehl

Lab Canada - * Printer friendly version * Email story to a friend * Send your comments to the editor * Personal News Alerts Related Items Topics * Academic Research * Collaborations Physicist pairs with pharmaceutical scientis - 0 views

www.labcanada.com/...ISArticle.asp

University of Toronto Innovative Organizations Ontario Cancer Institute MaRS Innovation University Health Network Life Sciences neuroscience

shared by Assunta Krehl on 23 Dec 09 - Cached
  • Assunta Krehl on 23 Dec 09
     
    To improve early detection and treatment of cancer, a pair of Toronto scientists, Dr David Jaffray, a senior scientist in the division of biophysics and bioimaging at the Ontario Cancer Institute and Dr Christine Allen, an associate professor in the Leslie Dan Faculty of Pharmacy at the University of Toronto has developed a technology that combines contrast agents with targeted, long-lasting nano-particles for use in multiple medical imaging platforms. MaRS Innovation (MI) and the University Health Network (UHN) have now entered into an agreement to collaboratively commercialize this promising technology. Dec 23, 2009
« First ‹ Previous 41 - 45 of 45
Showing 20▼ items per page